CryoLife® Europa

The International arena has become a significant part of CryoLife®'s business operations and continues to offer substantial potential for the years ahead. CryoLife Europa, Ltd., a wholly owned subsidiary of CryoLife, Inc., opened in September 1999. From its headquarters in Guildford, England, Europa serves all of our customers in Europe, the Middle East, India and Africa. Europa has direct sales networks in the UK and Germany. We utilize distributors in all other markets. The Company has recently outsourced its shipping logistics to ensure a timely and reliable delivery service for our customers throughout EMEA.

Europa's principal product is BioGlue®, which has been awarded three CE marks for its use in cardiac and vascular repair, pulmonary repair and soft tissue repair. CryoLife Europa, Ltd. can also facilitate the distribution of cardiac and vascular allograft tissues. The company also distributes CardioWrap™ as an anti-adhesion barrier in the UK.

Customers desiring information regarding the products and services we offer outside the United States should contact Europa at the following address:

CryoLife Europa, Ltd.
Bramley House
The Guildway
Old Portsmouth Road
Guildford, Surrey GU3 1LR
United Kingdom
Main: +44 (0) 1483 441030
Fax: +44 (0) 1483 452860

Almost all medical devices and products must go through clinical studies and regulatory reviews before they are commercially released, with different countries having different requirements before a product is approved for market. In this section, we have included a number of products that are available in certain countries and not yet available in the United States.